Paris, 03 July 2017 – Chronolife – start-up of the network iBionext specialized in the development of smart solutions for prediction in real-time chronic disease (including congestive heart failure and epilepsy) and care of the patients involved – has announced the appointment of Franck Le Meur as managing Director.
Download the free guide
Boost your gains
Franck Le Meur has the mission to support the growth strategy of Chronolife. He will oversee all development activities of the company, to the sides of Guillaume Chenegros, scientific Director and creator of this new technology of monitoring multiparameter – continuously and in parallel.
Franck Le Meur says : “I am very happy to contribute to impose the technology of rupture of Chronolife to the medicine of prevention. Its solutions will significantly improve the daily lives of patients and health professionals : provide and real-time alerts on the occurrence of an event or a crisis.”
For nearly 20 years, Franck has held several important functions both at the level of marketing/commercial, strategic, development of e-health, in France and internationally, within SANOFI that it had joined in 1995. Throughout his career, Franck has developed a significant expertise in multidisciplinary, including management of cross-cutting projects that it often initiates. Franck is a Doctor in pharmacy and holds a Master in Intelligence Marketing from HEC.
For Alexia Perouse, Director-General of iBionext, ” the expertise and leadership of Franck will be essential to support the growth strategy of Chronolife. The entrepreneurial spirit that animates it is an advantage to position the company as a leader in predictive medicine. ”
About Chronolife
Co-founded with iBionext in November 2015, Chronolife specializes in the predictive medicine of chronic diseases – congestive heart failure, epilepsy – developing a single solution for monitoring, multiparameter, continuous and in parallel. This technology allows you to make predictions based on an analysis of big data in health in real-time, on small units of computation, such as smartphones. The monitoring is integrated in a T-shirt connected, medical device, connected to the smartphone, thanks to a proprietary algorithm. Clinical trials are ongoing to December 2017.
About iBionext
Created in September 2015, iBionext is a management company that supports the development of innovative enterprises in the field of health. This initiative, launched in the form of a network of start-ups by Bernard Gilly in 2012, aims to transform ideas of technological breakthrough in innovative companies leaders in the areas of biotech, medtechs and medical devices connected to it. All of these companies are grouped within the ” Passage of the Innovation “, Paris, France. Since 2012, the network iBionext has participated in the creation of 8 companies – Pixium Vision (Euronext : PIX), GenSight Biologics (Euronext : SIGHT), Gecko Biomedical, Chronocam, ChronoLife, BrainEver, Tilak Healthcare and Brainiac, and has raised more than 300M (including the lifting of the growth Fund, iBionext Growth Fund). 6 clinical trials are underway in the world, 150 employees, specialized in high-tech sectors have joined these companies. IBionext Growth Fund has been created in 2016 to finance the growth of the new companies selected within the network iBionext.
For more information : http://ibionext.com/
Download the free guide
Boost your gains
